Structure of the N-terminal domain of ClpC1 in complex with the antituberculosis natural product ecumicin reveals unique binding interactions
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structure of the N-terminal domain of ClpC1 in complex with the antituberculosis natural product ecumicin reveals unique binding interactions
Authors
Keywords
-
Journal
Acta Crystallographica Section D-Structural Biology
Volume 76, Issue 5, Pages 458-471
Publisher
International Union of Crystallography (IUCr)
Online
2020-04-24
DOI
10.1107/s2059798320004027
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antimycobacterial Rufomycin Analogues from Streptomyces atratus Strain MJM3502
- (2020) Bin Zhou et al. JOURNAL OF NATURAL PRODUCTS
- Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus
- (2019) Mary P. Choules et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High-Resolution Structure of ClpC1-Rufomycin and Ligand Binding Studies Provide a Framework to Design and Optimize Anti-Tuberculosis Leads
- (2019) Nina M. Wolf et al. ACS Infectious Diseases
- Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix
- (2019) Dorothee Liebschner et al. Acta Crystallographica Section D-Structural Biology
- Cryo-EM structure of the ClpXP protein degradation machinery
- (2019) Christos Gatsogiannis et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Characterization of the Ohmyungsamycin Biosynthetic Pathway and Generation of Derivatives with Improved Antituberculosis Activity
- (2019) Eunji Kim et al. Biomolecules
- Conformation-Enabled Total Syntheses of Ohmyungsamycins A and B and Structural Revision of Ohmyungsamycin B
- (2018) Joonseong Hur et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Target discovery focused approaches to overcome bottlenecks in the exploitation of antimycobacterial natural products
- (2018) Rafael Baptista et al. Future Medicinal Chemistry
- Targeting the Proteostasis Network for Mycobacterial Drug Discovery
- (2018) Tania J. Lupoli et al. ACS Infectious Diseases
- New tuberculosis drug leads from naturally occurring compounds
- (2017) Diana Quan et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Ohmyungsamycins promote antimicrobial responses through autophagy activation via AMP-activated protein kinase pathway
- (2017) Tae Sung Kim et al. Scientific Reports
- Bacterial proteases, untapped antimicrobial drug targets
- (2016) Elizabeth Culp et al. JOURNAL OF ANTIBIOTICS
- Structure and Functional Properties of the Active Form of the Proteolytic Complex, ClpP1P2, fromMycobacterium tuberculosis
- (2016) Mi Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Acyldepsipeptide antibiotics kill mycobacteria by preventing the physiological functions of the ClpP1P2 protease
- (2016) Kirsten Famulla et al. MOLECULAR MICROBIOLOGY
- Anti-tuberculosis lead molecules from natural products targeting Mycobacterium tuberculosis ClpC1
- (2015) Hanki Lee et al. JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY
- The Cyclic Peptide Ecumicin Targeting ClpC1 Is Active against Mycobacterium tuberculosis In Vivo
- (2014) Wei Gao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Lassomycin, a Ribosomally Synthesized Cyclic Peptide, Kills Mycobacterium tuberculosis by Targeting the ATP-Dependent Protease ClpC1P1P2
- (2014) Ekaterina Gavrish et al. CHEMISTRY & BIOLOGY
- Discovery and Characterization of the Tuberculosis Drug Lead Ecumicin
- (2014) Wei Gao et al. ORGANIC LETTERS
- Structural Basis of Mycobacterial Inhibition by Cyclomarin A
- (2013) Dileep Vasudevan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural Dynamics of the MecA-ClpC Complex
- (2013) Jing Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ohmyungsamycins A and B: Cytotoxic and Antimicrobial Cyclic Peptides Produced by Streptomyces sp. from a Volcanic Island
- (2013) Soohyun Um et al. JOURNAL OF ORGANIC CHEMISTRY
- Bacterial proteolytic complexes as therapeutic targets
- (2012) Ravikiran M. Raju et al. NATURE REVIEWS DRUG DISCOVERY
- REFMAC5 for the refinement of macromolecular crystal structures
- (2011) Garib N. Murshudov et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- The Natural Product Cyclomarin Kills Mycobacterium Tuberculosis by Targeting the ClpC1 Subunit of the Caseinolytic Protease
- (2011) Esther K. Schmitt et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Mycobacterium tuberculosis ClpC1
- (2008) Narayani P. Kar et al. FEBS Journal
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search